February 1, 2023

Volume XIII, Number 32


January 31, 2023

Subscribe to Latest Legal News and Analysis

January 30, 2023

Subscribe to Latest Legal News and Analysis

Competition Currents October 2021 | Greater China & Japan

Greater China

​On Sept. 3, 2021, the State Administration for Market Regulation (SAMR) published 10 exemplary cases of enforcement of China’s Anti-Monopoly Law (AML) in 2020. Two international mergers—one in semiconductor and the other in medical product markets—are listed among the examples of mergers that SAMR approved with restrictive conditions. Both cases were cited as examples of SAMR’s enhanced scrutiny over international mergers based on analysis of their impact on China’s market. A brief recap of the two cases is as follows.

A.  Nvidia’s acquisition of Mellanox.

In 2019, Nvidia, a graphics processing unit (GPU) supplier, announced its intention to acquire Mellanox, a leading supplier of Ethernet and Infini band smart interconnect solutions. The US $6.9 billion transaction was approved by U.S. and EU regulators in the same year. In China, after a year-long scrutiny with protracted negotiation between SAMR and Nvidia, SAMR conditionally approved the acquisition on April 16, 2020, with certain restrictive conditions imposed.

In its opinion, SAMR identified each of GPU accelerators in which Nvidia is active, and private network interconnection equipment, Ethernet adapters, and data center servers in which Mellanox is active in the relevant markets. SAMR held that each pair of GPU accelerators/private network interconnection equipment and GPU accelerators/high-speed Ethernet adapters are neighboring markets, and that data center servers and ordinary Ethernet adapters are vertical markets. Following the conglomerate theories of harm and pointing to the complementary nature of the parties’ products, SAMR held that the acquisition would restrict competition in both China and global markets.

B.  Danaher’s acquisition of GE Biopharma.

SAMR’s other exemplary case was the conditional approval of Danaher’s acquisition of GE’s biopharma division on Feb. 28, 2020. In this case, the SAMR found that Danaher and GE had an overlap in 25 product markets for medical equipment. Both parties had significant market shares ranging between 10% to 25% in each market, and SAMR found that the transaction would thus result in a notable increase of Herfindahl-Hirschman Index (HHI) in such relevant markets, making entry into such markets difficult due to the technical and financial barriers. Therefore, SAMR concluded that the transaction would restrict competition in 10 particular product markets. Danaher and the combined business were ordered to divest some of the businesses to address monopoly concerns of SAMR. Specifically, the assets, including certain knowhow and trade secrets, of a research project called Project Emily will be sold to a third-party buyer, among other required divestitures. 


JFTC launches an investigation into IPO pricing.

The Japan Fair Trade Commission (JFTC) has launched an investigation into the pricing of initial public offerings (IPO), the first investigation of its kind. In Japan, the difference between the offer price and the opening share price has been larger than that in the United States and Europe, resulting in companies raising less money.

The JFTC reportedly sent questionnaires to approximately 100 companies listed on the Japanese stock market, requesting the contents of the negotiation with the underwriting securities companies regarding the determination of the IPO price, level of satisfaction with the offer price, etc. The JFTC also will work with the Financial Services Agency to ascertain the facts and scrutinize whether there are any problems under the Antimonopoly Law or in light of  Japan’s competition policy.

Pamela J. Marple, Yuji Ogiwara,  Stephen M. Pepper, Gillian Sproul, Hans Urlus, Dawn (Dan) Zhang, Pietro Missanelli, Anna Rajchert, Mari Arakawa, Filip Drgas, John Gao, Marta Kownacka, Massimiliano Pizzonia, Jose Abel Rivera-Pedroza, Chazz Sutherland, Ippei Suzuki, Rebecca Tracy Rotem and Alan W. Hersh contributed to this article. 

©2023 Greenberg Traurig, LLP. All rights reserved. National Law Review, Volume XI, Number 280

About this Author


Andrew G. Berg Chairs the Global Antitrust Litigation & Competition Regulation Practice and advises clients on litigation, mergers and acquisitions, and other antitrust and competition-related matters before the Federal Trade Commission (FTC), the Antitrust Division of the Department of Justice (DOJ), state attorneys general, and in private litigation. Andrew's practice includes a full range of antitrust transactional and mergers and acquisitions experience, including Hart-Scott-Rodino filings at the FTC and DOJ, and related merger analysis issues. He also counsels...

Gregory Casas, Greenberg Traurig Law Firm, Austin, Houston, Energy and Business Litigation Law

Gregory J. Casas is the Administrative Shareholder for the Austin office and focuses his practice on antitrust, complex business litigation, and energy and natural resources law. Greg's antitrust and complex business litigation practices are international in scope. His antitrust practice includes litigating price-fixing, bid-rigging, and market allocation claims, and providing counseling for DOJ/FTC investigations, joint venture formation, mergers and acquisitions, pricing plans, and other contractual relationships. Greg's complex business litigation experience includes...

Miguel Flores Bernés Antitrust & Competition Attorney Greenberg Traurig Mexico City, Mexico

Miguel Flores Bernés focuses his practice on antitrust and competition issues affecting clients in various industries, including government merger review, investigations of alleged anticompetitive conduct, litigation and counseling. He regularly represents clients before the two Mexican competition authorities: Comisión Federal de Competencia Económica and Instituto Federal de las Telecomunicaciones, and designed and implemented antitrust/competition compliance programs for clients in Mexico.

Prior to joining the firm, Miguel was a partner dedicated to antitrust and competition...

52 55-5029-0096
Víctor Manuel Frías Garcés Commercial Law Attorney Greenberg Traurig Mexico City, Mexico

The practice of Victor Manuel Frías is focused on commercial law, including competition, mergers and acquisitions and arbitration.

On the competition side, Mr. Frías has represented clients in numerous cartel investigations before the Competition Commission in different industries for over 20 years. He frequently represents clients in pre-merger filings. Mr. Frías has been ranked by different publications as one of Mexico’s premier competition attorneys. He often appears before Mexico’s Federal Specialized Courts in Competition and Telecommunications matters.

On the M&A...

52 55-5029-0020
Robert Gago Competition Law Attorney Greenberg Traurig Warsaw, Poland

Robert Gago is Head of the Competition Law Practice at the Greenberg Traurig Warsaw Office. He advises clients in the field of competition and consumer protection law and economic regulation. His experience includes representation in administrative anti-trust proceedings conducted by competition enforcement agencies. Robert advises on competition law aspects of M&A projects and represents clients in merger proceedings before the Polish Competition Authority as well as in procedures before the European Commission. He also represents undertakings in court proceedings regarding appeals...

48 22-690-6197